Hualan Biological Engineering Inc. Gains Profit    

Recently, Hualan Biological Engineering Inc. recorded a sale revenue of RMB234 million for the third quarter, up 83.28% year over year. The net profit was RMB113 million for Q3, increasing 171%. The total sale and net profit for the first three quarters were RMB434 million and RMB190 million respectively, up 33.61% and 61.28%. The high growth was attributed to the H1N1 flu vaccine manufacture.